Gaize

Gaize leads in spotting active impairment from drugs like cannabis, opiates, stimulants, alcohol, psychedelics, and dissociative anesthetics. They use automated versions of field sobriety tests proven accurate in many court cases and clinical trials. Now, businesses can use Gaize''s tech to boost workplace safety.

Benefits

Gaize offers an objective, real time solution for spotting drug impairment. It uses automated eye movement tests, which are very good at finding active cannabis impairment. Backed by a large clinical trial with 350 participants and over 500 million data points, Gaize''s results are reliable and easy to understand, supported by video evidence. The test takes only six minutes, making it great for frequent screening.

Use Cases

Gaize''s tech is perfect for businesses that need to ensure safety, especially where cannabis is legal. Companies can use it to screen employees before they do safety sensitive tasks. This helps cut down on preventable accidents and injuries. Gaize''s customers include some of the largest safety sensitive businesses worldwide.

Vibes

Gaize''s solution is well received, especially as cannabis legalization grows. The company''s vision to create a world where drivers and workers are verifiably sober before safety sensitive tasks resonates with many. Customers like the practical and reliable nature of Gaize''s tech, which helps keep roads and workplaces safe.

Additional Information

Ken Fichtler founded Gaize to tackle the issue of cannabis impaired drivers and workers. The company aims to improve its tech through continued machine learning analysis and more clinical trials. Gaize plans to make a single device that can detect and classify impairment from any drug, including opiates, stimulants, and other impairing substances.